Human AME (mass balance) studies

9 Jan 2023

In this white paper, QPS describes human AME (hAME) studies and the complexities of carrying out these trials, particularly with respect to managing and conducting radiolabelled hAME.

QPS Clinical Phase I/IIa Development Services

QPS

Moving quickly and safely through Phase I/IIa trials is critical to successful drug development.  The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually. 

(0)

Links

Tags

Human AME (mass balance) studies